Andrea Luchetti’s Post

View profile for Andrea Luchetti, graphic

EMEA Market Development Manager - Oncology presso Thermo Fisher Scientific

Did you know that the turnaround times (TATs) for oncology biomarker profiling can be as long as 25 days? This extended timeframe has a significant impact on patients' outcomes. To address this issue, we invite you to join our webinar on rapid molecular profiling, where we will discuss the importance of timely biomarker analysis and its role in optimizing patient outcomes. #thermofisheremp

Live Webinar: Rapid Molecular Profiling is Essential to Optimize Patient Outcomes - Real-World Data Analysis

Live Webinar: Rapid Molecular Profiling is Essential to Optimize Patient Outcomes - Real-World Data Analysis

thepathologist.videomarketingplatform.co

Marta Hall

Associate Director Global Market Development Clinical Oncology NGS

11mo

To view or add a comment, sign in

Explore topics